Table 1.

Statistical analysis of molecular adhesion models



Model 1

Model 2
q = 0.1
q = 0.2
q = 0.3
q = 0.4
w, dyne/cm−2
koff,mut, s−1
P, 10−3
koff,mut, s−1
P, 10−3
koff,mut, s−1
P, 10−3
koff,mut, s−1
P, 10−3
koff,mut, s−1
P, 10−3
0.5   0.846   14.4   0.828   1.6*  0.810   .2*  0.790   .0*  0.768   .0* 
0.5   1.008   83.9   0.976   23.4   0.944   4.9*  0.911   .7*  0.877   .1* 
0.5   0.788   1.9*  0.777   .2*  0.766   .0*  0.752   .0*  0.737   .0* 
0.5   0.682   2.7*  0.670   .2*  0.658   .0*  0.645   .0*  0.632   .0* 
0.5   0.853   198.9   0.823   76.0   0.795   23.6   0.766   5.9*  0.736   .12* 
1.0   1.144   274.9   1.099   111.4   1.057   035.0   1.017   8.3*  0.979   1.4* 
1.0   1.048   51.3   1.016   12.5   0.985   2.3*  0.954   .3*  0.924   .0* 
1.0   1.136   339.1   1.093   141.8   1.052   46.1   1.013   11.4   0.975   2.1* 
1.0   0.957   54.21   0.935   9.9*  0.913   1.7*  0.890   .2*  0.866   .0* 
1.0   0.964   53.9   0.943   11.4   0.922   1.7*  0.899   .2*  0.876   .0* 
1.5   1.370   56.1   1.336   10.1   1.300   2.3*  1.262   .4*  1.222   .1* 
1.5   1.826   840.1   1.731   655.4   1.636   448.5   1.543   268.5   1.450   139.6  
1.5   1.473   140.5   1.421   62.2   1.371   21.2   1.321   5.2*  1.272   1.0* 
1.5   1.175   78.1   1.152   3.4*  1.127   .5*  1.101   .0*  1.072   .0* 
1.5   1.472   135.7   1.423   55.1   1.373   18.8   1.321   5.3*  1.268   1.2* 
2.0   1.894   67.6   1.822   25.1   1.752   7.6*  1.682   1.8*  1.609   .3* 
2.0   2.313   969.2   2.177   934.7   2.043   877.6   1.911   781.8   1.782   604.3  
2.0   2.315   992.6   2.180   965.0   2.048   881.8   1.918   736.0   1.791   553.8  
2.0   1.890   201.1   1.813   78.9   1.738   24.3   1.664   5.7*  1.590   1.0* 
2.0
 
1.785
 
566.4
 
1.704
 
316.0
 
1.628
 
139.0
 
1.555
 
45.4
 
1.484
 
11.1*
 


Model 1

Model 2
q = 0.1
q = 0.2
q = 0.3
q = 0.4
w, dyne/cm−2
koff,mut, s−1
P, 10−3
koff,mut, s−1
P, 10−3
koff,mut, s−1
P, 10−3
koff,mut, s−1
P, 10−3
koff,mut, s−1
P, 10−3
0.5   0.846   14.4   0.828   1.6*  0.810   .2*  0.790   .0*  0.768   .0* 
0.5   1.008   83.9   0.976   23.4   0.944   4.9*  0.911   .7*  0.877   .1* 
0.5   0.788   1.9*  0.777   .2*  0.766   .0*  0.752   .0*  0.737   .0* 
0.5   0.682   2.7*  0.670   .2*  0.658   .0*  0.645   .0*  0.632   .0* 
0.5   0.853   198.9   0.823   76.0   0.795   23.6   0.766   5.9*  0.736   .12* 
1.0   1.144   274.9   1.099   111.4   1.057   035.0   1.017   8.3*  0.979   1.4* 
1.0   1.048   51.3   1.016   12.5   0.985   2.3*  0.954   .3*  0.924   .0* 
1.0   1.136   339.1   1.093   141.8   1.052   46.1   1.013   11.4   0.975   2.1* 
1.0   0.957   54.21   0.935   9.9*  0.913   1.7*  0.890   .2*  0.866   .0* 
1.0   0.964   53.9   0.943   11.4   0.922   1.7*  0.899   .2*  0.876   .0* 
1.5   1.370   56.1   1.336   10.1   1.300   2.3*  1.262   .4*  1.222   .1* 
1.5   1.826   840.1   1.731   655.4   1.636   448.5   1.543   268.5   1.450   139.6  
1.5   1.473   140.5   1.421   62.2   1.371   21.2   1.321   5.2*  1.272   1.0* 
1.5   1.175   78.1   1.152   3.4*  1.127   .5*  1.101   .0*  1.072   .0* 
1.5   1.472   135.7   1.423   55.1   1.373   18.8   1.321   5.3*  1.268   1.2* 
2.0   1.894   67.6   1.822   25.1   1.752   7.6*  1.682   1.8*  1.609   .3* 
2.0   2.313   969.2   2.177   934.7   2.043   877.6   1.911   781.8   1.782   604.3  
2.0   2.315   992.6   2.180   965.0   2.048   881.8   1.918   736.0   1.791   553.8  
2.0   1.890   201.1   1.813   78.9   1.738   24.3   1.664   5.7*  1.590   1.0* 
2.0
 
1.785
 
566.4
 
1.704
 
316.0
 
1.628
 
139.0
 
1.555
 
45.4
 
1.484
 
11.1*
 
*

When P values corresponding to tests of models are less than 10 × 10−3, the model fails the KS test. The best model is model 1, which neglects the contribution of wild-type bonding to the pause time of platelets from the heterozygous patient. Model 2 explicitly accounts for the possibility of tether bond formation via mutant and wild-type interactions. However, as the probability of wild-type bonding is increased, the quality of the model deteriorates. Hypothesis testing demonstrates that model 1 is the best model of adhesion of the platelets from the heterozygous patients.

or Create an Account

Close Modal
Close Modal